AAPL 172.03 +0.12 (+0.07%)MSFT 107.14 +0.57 (+0.53%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 172.03 +0.12 (+0.07%)MSFT 107.14 +0.57 (+0.53%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Balance Sheet APEN Quote Apollo Endo

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 9 19 31
ShortTermInvest 0 0 0
Cash 9 19 31
AccountReceivab 0 11 12
Inventories 0 12 14
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 9 44 58
PPE 1 11 14
AccumulatedDepr -1 -4 -7
NetPPE 0 7 7
EquityAndOtherI 0 0 0
Goodwill 0 7 7
IntangibleAsset 2 43 36
OtherLTAssets 0 1 1
TotalNonCurrent 2 59 51
TotalAssets 12 102 109
ShortTermDebt 0 0 0
AccountsPayable 0 5 18
TaxesPayable 0 0 0
AccruedLiabilit 1 6 8
DeferredRevenue 0 0 0
OtherCurrentLia 0 9 0
TotalCurrentLia 1 20 26
Debt 0 39 33
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 0 0 0
TotalNonCurrent 0 39 33
TotalLiabilitie 1 60 59
CommonStock 0 0 0
AdditionalPaidI 87 191 225
RetainedEarning -76 -150 -177
AccumulatedOthe 0 1 2
TotalStockholde 11 42 50
TotalLiabilitie 12 102 109
Apollo Endosurgery Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Apollo Endosurgery Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.